Physiological implications of reduced glutathione reductase activity of red blood cells in human ariboflavinosis.
D004912:Erythrocytes / Q000201:enzymology* / Q000503:physiopathology; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D005980:Glutathione Reductase / Q000097:blood*; D006461:Hemolysis; D006358:Hot Temperature; D006801:Humans; D007700:Kinetics; D009249:NADP; D010659:Phenylhydrazines; D012256:Riboflavin / Q000627:therapeutic use; D012257:Riboflavin Deficiency / Q000097:blood / Q000188:drug therapy / Q000201:enzymology* / Q000503:physiopathology
D010659:Phenylhydrazines; D009249:NADP; D005954:Glucosephosphate Dehydrogenase; D005980:Glutathione Reductase; D012256:Riboflavin